Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A synthetic bacterial community made of human milk isolated strains is an effective strategy to prevent food allergy in a mouse model.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026

Same author

Neuroplastic adaptation in somatosensory representation in congenital limb deficiency: A case-control study.

Neuropsychologia·2025

Same author

Electrodiagnostic criteria for neuromuscular transmission disorders suggested by a European consensus group.

Clinical neurophysiology practice·2025

Same author

A Gestational Supplementation With 2'-Fucosyllactose Is an Effective Strategy to Prevent Food Allergy.

Allergy·2024

Same author

Estimating motor unit numbers from a CMAP scan: Repeatability study on three muscles at 15 centres.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2023

Same author

Low intensity exercise training in patients with amyotrophic lateral sclerosis - factors influencing eligibility and compliance to the clinical trial.

Neurological research·2023

Same journal

Evaluation of an open-face 8-channel transmit 64-channel receive 7T head coil for neuroimaging.

Frontiers in neuroscience·2026

Same journal

Acoustic stimulation in pain management: neurobiological mechanisms and clinical applications-a narrative review.

Frontiers in neuroscience·2026

Same journal

Local brain connectome parameters across the spectrum of clinical cognitive decline.

Frontiers in neuroscience·2026

Same journal

Body mass index affects EEG microstate dynamics through blood viscosity in high-altitude environments.

Frontiers in neuroscience·2026

Same journal

Disrupted glymphatic function and its relationship with sleep and cognitive impairment in ME/CFS assessed via DTI-ALPS.

Frontiers in neuroscience·2026

Same journal

Neuromorphic-inspired multi-view global-local fusion for IR-UWB radar dynamic gesture recognition.

Frontiers in neuroscience·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 18, 2025

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis.

B Kuraszkiewicz¹, H Goszczyńska¹, T Podsiadły-Marczykowska¹

¹Department of Methods of Brain Imaging and Functional Research of Nervous System, Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland.

Frontiers in Neuroscience

|June 13, 2020

Summary

This summary is machine-generated.

Preventive strategies targeting aging mechanisms may help amyotrophic lateral sclerosis (ALS) patients. Early identification of individuals at risk for ALS could enable proactive interventions, potentially improving patient outcomes.

Keywords:

aging amyotrophic lateral sclerosis dietary habits exercise gut microbiome psychological stress

More Related Videos

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Related Experiment Videos

Last Updated: Dec 18, 2025

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Area of Science:

Neuroscience
Gerontology
Molecular Biology

Background:

Amyotrophic lateral sclerosis (ALS) lacks established pathogenesis and effective therapies.
Preventive measures for ALS are often considered futile.
Aging shares molecular pathways with ALS.

Purpose of the Study:

To explore the shared molecular mechanisms between ALS and aging.
To investigate the potential of anti-aging strategies for ALS management and prevention.
To highlight the possibility of early risk identification for ALS.

Main Methods:

Comparative analysis of molecular mechanisms in aging and ALS.
Review of existing anti-aging interventions (diet, exercise).
Exploration of recent advancements in early disease risk detection.

Main Results:

ALS and aging share fundamental molecular pathways.
Established anti-aging strategies show potential for ameliorating ALS symptoms.
Early identification of ALS risk is becoming increasingly feasible.

Conclusions:

Anti-aging interventions, including diet and exercise, may offer therapeutic benefits for ALS patients.
These strategies could be adapted for ALS prevention in at-risk individuals.
Advances in risk identification may soon facilitate early preventive interventions for ALS.